E. Festa

Hepatitis B virus reactivation after effective sofosbuvir and ribavirin treatment in a patient with occult hepatitis B virus infection.

F. Castelli, A. Vavassori, M. Viganò, 2017, The new microbiologica.

Colitis during new direct-acting antiviral agents (DAAs) therapy with sofosbuvir, simeprevir and ribavirin for genotype 1b hepatitis C

V. Villanacci, F. Castelli, I. Izzo, 2016, Infection.

Schistosomiasis, strongyloidiasis and Chagas disease: the leading imported Neglected Tropical Diseases in Italy.

P. Olliaro, F. Gobbi, F. Castelli, 2019, Journal of travel medicine.

Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus

A. Lazzarin, L. Calza, V. Vullo, 2018, The Journal of antimicrobial chemotherapy.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Lymphoproliferative disease with mixed cryoglobulinemia and hyperviscosity syndrome in an HIV-infected patient: HCV is the only culprit.

F. Castelli, I. Izzo, C. Cattaneo, 2017, The New Microbiologica.